Risk factors for lymphedema in a prospective breast cancer survivorship study: The pathways study

Archives of Surgery

Volumn 145, Issue 11, 2010, Pages 1055-1063

  Kwan, Marilyn L ^a   Darbinian, Jeanne ^a   Schmitz, Kathryn H ^b   Citron, Rebecca ^a   Partee, Paula ^a   Kutner, Susan E ^c   Kushi, Lawrence H ^a  

^a DIVISION OF RESEARCH   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c San Jose Medical Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACADEMIC ACHIEVEMENT; ADULT; AFRICAN AMERICAN; AGED; ARTICLE; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER HORMONE THERAPY; CANCER RADIOTHERAPY; CANCER SURVIVOR; COHORT ANALYSIS; CORRELATION ANALYSIS; DEMOGRAPHY; FEMALE; FOLLOW UP; HUMAN; INCIDENCE; LIFESTYLE; LYMPH NODE DISSECTION; LYMPHEDEMA; MAJOR CLINICAL STUDY; OBESITY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RACE DIFFERENCE; RISK ASSESSMENT; RISK FACTOR;

BREAST NEOPLASMS; CALIFORNIA; CHI-SQUARE DISTRIBUTION; DEMOGRAPHY; EDUCATIONAL STATUS; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; LIFE STYLE; LYMPHATIC METASTASIS; LYMPHEDEMA; MIDDLE AGED; NEOPLASM INVASIVENESS; OBESITY; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RISK FACTORS; SURVIVORS;

EID: 78449251556     PISSN: 00040010     EISSN: 15383644     Source Type: Journal    
DOI: 10.1001/archsurg.2010.231     Document Type: Article

References (51)

1. American Cancer Society. http://www.cancer.org/. Accessed April 12, 2008.
2. Erickson VS, Pearson ML, Ganz PA, Adams J, Kahn KL. Arm edema in breast cancer patients. J Natl Cancer Inst. 2001;93(2):96-111.
3. Petrek JA, Pressman PI, Smith RA. Lymphedema: current issues in research and management. CA Cancer J Clin. 2000;50(5):292-307.
4. Armer JM. The problem of post-breast cancer lymphedema: impact and measurement issues. Cancer Invest. 2005;23(1):76-83.
5. National Lymphedema Network. http://www.lymphnet.org/. Accessed April 12, 2008.
6. Paskett ED, Naughton MJ, McCoy TP, Case LD, Abbott JM. The epidemiology of arm and hand swelling in premenopausal breast cancer survivors. Cancer Epidemiol Biomarkers Prev. 2007;16(4):775-782.
7. Petrek JA, Heelan MC. Incidence of breast carcinoma-related lymphedema. Cancer. 1998;83(12, suppl American):2776-2781.
8. Humble CA. Lymphedema: incidence, pathophysiology, management, and nursing care. Oncol Nurs Forum. 1995;22(10):1503-1509.
9. McWayne J, Heiney SP. Psychologic and social sequelae of secondary lymphedema: a review. Cancer. 2005;104(3):457-466. (Pubitemid 41022801)
10. Segerström K, Bjerle P, Nyström A. Importance of time in assessing arm and hand function after treatment of breast cancer. Scand J Plast Reconstr Surg Hand Surg. 1991;25(3):241-244.
11. Tobin MB, Lacey HJ, Meyer L, Mortimer PS. The psychological morbidity of breast cancer-related arm swelling: psychological morbidity of lymphoedema. Cancer. 1993;72(11):3248-3252.
12. Maunsell E, Brisson J, Deschênes L. Arm problems and psychological distress after surgery for breast cancer. Can J Surg. 1993;36(4):315-320.
13. Velanovich V, Szymanski W. Quality of life of breast cancer patients with lymphedema. Am J Surg. 1999;177(3):184-188. (Pubitemid 29183869)
14. Passik S, Newman M, Brennan M, Holland J. Psychiatric consultation for women undergoing rehabilitation for upper-extremity lymphedema following breast cancer treatment. J Pain Symptom Manage. 1993;8(4):226-233.
15. Engel J, Kerr J, Schlesinger-Raab A, Sauer H, Hölzel D. Axilla surgery severely affects quality of life: results of a 5-year prospective study in breast cancer patients. Breast Cancer Res Treat. 2003;79(1):47-57. (Pubitemid 36561042)
16. Kwan W, Jackson J, Weir LM, Dingee C, McGregor G, Olivotto IA. Chronic arm morbidity after curative breast cancer treatment: prevalence and impact on quality of life. J Clin Oncol. 2002;20(20):4242-4248.
17. Kornblith AB, Herndon JE II, Weiss RB, et al. Long-term adjustment of survivors of early-stage breast carcinoma, 20 years after adjuvant chemotherapy. Cancer. 2003;98(4):679-689.
18. Ahmed RL, Prizment A, Lazovich D, Schmitz KH, Folsom AR. Lymphedema and quality of life in breast cancer survivors: the Iowa Women's Health Study [published online ahead of print November 10, 2008]. J Clin Oncol. 2008;26(35):5689-5696. doi:10.1200/JCO.2008.16.4731.
19. Kwan ML, Ambrosone CB, Lee MM, et al. The Pathways Study: a prospective study of breast cancer survivorship within Kaiser Permanente Northern California [published online ahead of print May 14, 2008]. Cancer Causes Control. 2008;19(10):1065-1076. doi:10.1007/s10552-008-9170-5.
20. Harwood CA, Mortimer PS. Causes and clinical manifestations of lymphatic failure. Clin Dermatol. 1995;13(5):459-471.
21. Cheville AL, McGarvey CL, Petrek JA, Russo SA, Thiadens SR, Taylor ME. The grading of lymphedema in oncology clinical trials. Semin Radiat Oncol. 2003;13(3):214-225. (Pubitemid 36962645)
22. National Lymphedema Network Medical Advisory Committee. Training of lymphedema therapists. http://www.lymphnet.org/lymphedemaFAQs/positionPapers. htm. Accessed December 22, 2008.
23. World Health Organization. International Classification of Diseases, Ninth Revision (ICD-9). Geneva, Switzerland: World Health Organization; 1977.
24. Staten LK, Taren DL, Howell WH, et al. Validation of the Arizona Activity Frequency Questionnaire using doubly labeled water. Med Sci Sports Exerc. 2001;33(11):1959-1967.
25. Oehrli MD, Quesenberry CP, Leyden W. 2006 Annual Report on Trends, Incidence, and Outcomes. Oakland: Kaiser Permanente Northern California Cancer Registry; 2006.
26. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc. 1958;53:457-481.
27. Cox DR, Oakes D. Analysis of Survival Data. New York, NY: Chapman & Hall; 1994.
28. Hayes SC, Janda M, Cornish B, Battistutta D, Newman B. Lymphedema after breast cancer: incidence, risk factors, and effect on upper body function. J Clin Oncol. 2008;26(21):3536-3542.
29. Harris SR, Niesen-Vertommen SL. Challenging the myth of exercise-induced lymphedema following breast cancer: a series of case reports. J Surg Oncol. 2000;74(2):95-99.
30. Turner J, Hayes S, Reul-Hirche H. Improving the physical status and quality of life of women treated for breast cancer: a pilot study of a structured exercise intervention. J Surg Oncol. 2004;86(3):141-146.
31. McKenzie DC, Kalda AL. Effect of upper extremity exercise on secondary lymphedema in breast cancer patients: a pilot study. J Clin Oncol. 2003;21(3):463-466.
32. Ahmed RL, Thomas W, Yee D, Schmitz KH. Randomized controlled trial of weight training and lymphedema in breast cancer survivors. J Clin Oncol. 2006;24(18):2765-2772. (Pubitemid 46630574)
33. Schmitz KH, Ahmed RL, Troxel A, et al. Weight lifting in women with breastcancer- related lymphedema. N Engl J Med. 2009;361(7):664-673.
34. Clark B, Sitzia J, Harlow W. Incidence and risk of arm oedema following treatment for breast cancer: a three-year follow-up study [published online ahead of print April 8, 2005]. QJM. 2005;98(5):343-348. doi:10.1093/qjmed/ hci053.
35. Soran A, D'Angelo G, Begovic M, et al. Breast cancer-related lymphedema: what are the significant predictors and how they affect the severity of lymphedema? Breast J. 2006;12(6):536-543.
36. Werner RS, McCormick B, Petrek J, et al. Arm edema in conservatively managed breast cancer: obesity is a major predictive factor. Radiology. 1991;180(1):177-184.
37. Brorson H. Adipose tissue in lymphedema: the ignorance of adipose tissue in lymphedema. Lymphology. 2004;37(4):175-177.
38. American Cancer Society. http://www.cancer.org/docroot/CDG/content/CDG- dexamethasone.asp. Accessed December 22, 2008.
39. Walsh D, Avashia J. Glucocorticoids in clinical oncology. Cleve Clin JMed. 1992;59(5):505-515.
40. Schrenk P, Rieger R, Shamiyeh A, Wayand W. Morbidity following sentinel lymph node biopsy versus axillary lymph node dissection for patients with breast carcinoma. Cancer. 2000;88(3):608-614. (Pubitemid 30056936)
41. Purushotham AD, Upponi S, Klevesath MB, et al. Morbidity after sentinel lymph node biopsy in primary breast cancer: results from a randomized controlled trial. J Clin Oncol. 2005;23(19):4312-4321.
42. Helms G, Kuhn T, Moser L, Remmel E, Kreienberg R. Shoulder-arm morbidity in patients with sentinel node biopsy and complete axillary dissection: data from a prospective randomised trial [published online ahead of print October 5, 2008]. Eur J Surg Oncol. 2009;35(7):696-701.
43. Schulze T, Mucke J, Markwardt J, Schlag PM, Bembenek A. Long-term morbidity of patients with early breast cancer after sentinel lymph node biopsy compared to axillary lymph node dissection. J Surg Oncol. 2006;93(2):109-119.
44. Husted Madsen A, Haugaard K, Soerensen J, et al. Arm morbidity following sentinel lymph node biopsy or axillary lymph node dissection: a study from the Danish Breast Cancer Cooperative Group. Breast. 2008;17(2):138-147. (Pubitemid 351478254)
45. McLaughlin SA, Wright MJ, Morris KT, et al. Prevalence of lymphedema in women with breast cancer 5 years after sentinel lymph node biopsy or axillary dissection: objective measurements [published online ahead of print October 6, 2008]. J Clin Oncol. 2008;26(32):5213-5219. doi:10.1200/JCO.2008.16.3725.
46. Francis WP, Abghari P, Du W, Rymal C, Suna M, Kosir MA. Improving surgical outcomes: standardizing the reporting of incidence and severity of acute lymphedema after sentinel lymph node biopsy and axillary lymph node dissection. Am J Surg. 2006;192(5):636-639.
47. Lucci A, McCall LM, Beitsch PD, et al; American College of Surgeons Oncology Group. Surgical complications associated with sentinel lymph node dissection (SLND) plus axillary lymph node dissection compared with SLND alone in the American College of Surgeons Oncology Group Trial Z0011 [published online ahead of print May 7, 2007]. J Clin Oncol. 2007;25(24):3657-3663. doi:10.1200/JCO.2006.07.4062.
48. Krag DN, Anderson SJ, Julian TB, et al; National Surgical Adjuvant Breast and Bowel Project. Technical outcomes of sentinel-lymph-node resection and conventional axillary-lymph-node dissection in patients with clinically nodenegative breast cancer: results from the NSABP B-32 randomised phase III trial. Lancet Oncol. 2007;8(10):881-888.
49. Cochran AJ, Roberts AA, Saida T. The place of lymphatic mapping and sentinel node biopsy in oncology. Int J Clin Oncol. 2003;8(3):139-150.
50. Yen TW, Fan X, Sparapani R, Laud PW, Walker AP, Nattinger ABA. A contemporary, population-based study of lymphedema risk factors in older women with breast cancer [published online ahead of print February 5, 2009]. Ann Surg Oncol. 2009;16(4):979-988. doi:10.1245/s10434-009-0347-2.
51. Eversley R, Estrin D, Dibble S, Wardlaw L, Pedrosa M, Favila-Penney W. Post-treatment symptoms among ethnic minority breast cancer survivors. Oncol Nurs Forum. 2005;32(2):250-256.